|
業務類別
|
Biotechnology |
|
業務概覽
|
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improvedproducts and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs. |
| 公司地址
| 20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876 |
| 電話號碼
| +1 301 556-9900 |
| 傳真號碼
| -- |
| 公司網頁
| http://www.precigen.com |
| 員工數量
| 143 |
| Mr. Harry Thomasian, Jr |
Chief Financial Officer and Principal Accounting Officer |
美元 486.50K |
16/05/2025 |
| Mr. Rutul R. Shah |
Chief Operating Officer |
美元 452.12K |
16/05/2025 |
| Dr. Helen Sabzevari, PhD |
President; Director; Chief Executive Officer and Chief Executive Officer, PGEN Therapeutics, Inc. |
美元 1.00M |
16/05/2025 |
| Mr. Phil Tennant |
Chief Commercial Officer |
美元 215.77K |
16/05/2025 |
| Mr. Donald P. Lehr |
Chief Legal Officer |
美元 575.00K |
16/05/2025 |
|
|
| Mr. Fred Hassan |
Independent Director |
16/05/2025 |
| Mr. Jeffrey B. Kindler, J.D. |
Independent Director |
16/05/2025 |
| Ms. Nancy Howell Agee |
Independent Director |
16/05/2025 |
| Dr. Helen Sabzevari, PhD |
President; Director; Chief Executive Officer and Chief Executive Officer, PGEN Therapeutics, Inc. |
16/05/2025 |
| Mr. Cesar L. Alvarez |
Independent Director |
16/05/2025 |
| Ms. Vinita D. Gupta |
Independent Director |
16/05/2025 |
| Mr. Steven Frank |
Independent Director |
16/05/2025 |
| Mr. James S. Turley |
Lead Independent Director |
16/05/2025 |
| Mr. Randal J. Kirk |
Executive Chairman of the Board |
16/05/2025 |
|
|
|
|
